piperazine derivatives using N- (indolecarbonyl)

The invention relates to the use of compounds of formula (I), wherein R , R , R and R have the designations cited in patent claim 1, and to the physiologically acceptable salts and solvates of said compounds, for the treatment of obesity, sub-types of anxiety, sub-types of schizophrenia and types of dementia of various origins.